News about Drug Discovery & Development

ENCell Signs MOU with CRC to Enter Japanese Market

Following the latest MoU, the two companies plan to discuss a contractual agreement for the transfer of ENCell’s CDMO technology and expertise.

Drug Discovery & Development | 17/03/2025 | By Aishwarya |  209

Glenmark Unveils Polyethylene Glycol 3350, Powder for Solution, 17 Grams/Capful

Glenmark Pharmaceuticals is a research-led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.

Drug Discovery & Development | 10/03/2025 | By Aishwarya |  596

Zydus Lifesciences Introduces ANVIMO for Kidney and HSCT Transplant Patients

CMV infection remains one of the most serious complications in transplant patients, often leading to graft failure, decreased survival and prolonged hospital stays.

Drug Discovery & Development | 06/03/2025 | By Aishwarya |  522

Zydus Lifesciences to Launch Protection Against New Strain of Influenza Virus in India

Zydus is set to launch VaxiFlu-4, India’s first quadrivalent influenza vaccine of the season, formulated as per WHO’s 2025 southern hemisphere recommendations.

Drug Discovery & Development | 01/03/2025 | By Manvi |  650

Eisai Signs Deal to Develop Tasurgratinib in Greater China Region with SciClone

Eisai will maintain the rights to tasurgratinib worldwide outside of the licensed regions and continue to manufacture and market it in Japan, where it has been already launched.

Drug Discovery & Development | 01/03/2025 | By Aishwarya |  447

BridGene Biosciences Signs Deal with Takeda to Discover Small Molecule Drugs

Under the terms of the collaboration, BridGene will use its chemoproteomics platform, IMTAC™, to discover novel small molecule drug candidates against challenging targets in immunology and neurology.

Drug Discovery & Development | 26/02/2025 | By Aishwarya |  498

Tiziana Life Sciences Signs Deal for Product Development Services with Renaissance Lakewood

Under this agreement, Renaissance will use its extensive expertise in pharmaceutical-nasal product development and manufacturing to support the production of intranasal foralumab, ensuring compliance with the highest quality and regulatory requirements.

Drug Discovery & Development | 24/02/2025 | By Aishwarya |  230

Biogen and Stoke Therapeutics to Develop and Commercialize Zorevunersen

Zorevunersen is an investigational antisense oligonucleotide (ASO) that targets the SCN1A gene, the underlying cause of most cases of Dravet syndrome.

Drug Discovery & Development | 20/02/2025 | By Aishwarya |  414

Innocan Pharma Secures its First Patent in India for its Liposomal CBD Injection

This granted patent protects Innocan's synthetic Cannabidiol-loaded Liposome Injection Platform (LPT-CBD), designed for precise dosing and sustained release of Synthetic CBD into the bloodstream.

Drug Discovery & Development | 19/02/2025 | By Aishwarya |  543

Glenmark Pharmaceuticals Inc., USA Launches Clindamycin Phosphate Foam, 1 percent

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1 percent.

Drug Discovery & Development | 12/02/2025 | By Manvi |  295